[HTML][HTML] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su, ZP Hou… - Translational …, 2022 - Springer
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, YV Sun, HW Dou, JH Su… - Translational …, 2022 - portal.research.lu.se
Background: Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
[HTML][HTML] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou… - Translational …, 2022 - translationalneurodegeneration …
Growing evidence suggests an association between Parkinson's disease (PD) and diabetes
mellitus (DM). At the cellular level, long-term elevated levels of glucose have been shown to …
mellitus (DM). At the cellular level, long-term elevated levels of glucose have been shown to …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su… - Translational …, 2022 - search.ebscohost.com
Background: Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou… - Translational …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
[HTML][HTML] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su… - Translational …, 2022 - ncbi.nlm.nih.gov
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, YV Sun, HW Dou, JH Su… - Translational …, 2022 - lup.lub.lu.se
Background: Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
Long-term hyperglycemia aggravates [alpha]-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su… - Translational …, 2022 - go.gale.com
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su… - Translational …, 2022 - europepmc.org
Background Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long-term elevated levels of glucose have …
[PDF][PDF] Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model
YQ Lv, L Yuan, Y Sun, HW Dou, JH Su, ZP Hou… - 2022 - translationalneurodegeneration …
Background: Growing evidence suggests an association between Parkinson's disease (PD)
and diabetes mellitus (DM). At the cellular level, long‑term elevated levels of glucose have …
and diabetes mellitus (DM). At the cellular level, long‑term elevated levels of glucose have …